AAREYDRUGS · Healthcare · Drug Manufacturers - Specialty & Generic
| Share price | ₹85.58 |
| Market cap | ₹243 Cr |
| P/E ratio | 61.6 |
| P/B ratio | 1.6 |
| ROE | 14.0% |
| ROCE | 6.8% |
| Book value | ₹52.87 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹472 Cr | ₹4 Cr | 0.9% |
| 2025 | ₹474 Cr | ₹4 Cr | 0.2% |
| 2024 | ₹395 Cr | ₹5 Cr | 0.7% |
| 2023 | ₹413 Cr | ₹4 Cr | 0.5% |
| 2022 | — | — | — |
Aarey Drugs & Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India. The company offers intermediates, including mono methyl urea, di methyl urea, ortho para nitro anisole, 2-bromomethyl-1,3-dioxolane, and uracil. It also provides active pharmaceutical ingredients, such as metformin HCl, mefenamic acid, and doxofylline. In addition, the company trades chemicals and solvents, including aromatic chemicals, chemical acids, chlor-alkali, glycols and glycol ethers, fiber intermediates, an